Literature DB >> 10873882

Cardiopulmonary events during hemodialysis: effects of dialysis membranes and dialysate buffers.

M A Munger1, A Ateshkadi, A K Cheung, K K Flaharty, G J Stoddard, E H Marshall.   

Abstract

Adverse cardiac and pulmonary events are frequently observed during hemodialysis and contribute to significant morbidity and mortality. The temporal relationship between these events during the intradialytic period has not been well defined. To examine the event rate and timing of silent ischemia, cardiac ectopy, and hypoxemia, we conducted a prospective, single-blind, randomized study of 10 subjects undergoing maintenance hemodialysis with four contiguous combinations of dialysis membranes (cuprammonium or polysulfone) and dialysates (acetate or bicarbonate). The frequency of oxygen desaturation events peaked during the first 2 hours, whereas silent myocardial ischemia and supraventricular ectopies occurred more often in the later hours. Ventricular ectopy occurred steadily throughout the intradialytic period. The combination of acetate dialysis and cuprammonium membrane is associated with the most frequent events. We conclude that cardiopulmonary events can occur frequently during hemodialysis, and the frequency is dependent on the type of dialysis membrane and dialysate buffer used.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873882     DOI: 10.1053/ajkd.2000.8285

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

Review 1.  High-flux versus low-flux membranes for end-stage kidney disease.

Authors:  Suetonia C Palmer; Kannaiyan S Rabindranath; Jonathan C Craig; Paul J Roderick; Francesco Locatelli; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 2.  Arrhythmic complication in cardiorenal syndrome.

Authors:  Luigi Padeletti; Lisa Innocenti; Alessandro Paoletti Perini; Edoardo Gronda
Journal:  Heart Fail Rev       Date:  2011-11       Impact factor: 4.214

Review 3.  Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine.

Authors:  Bernard Canaud; Stefano Stuard; Frank Laukhuf; Grace Yan; Maria Ines Gomez Canabal; Paik Seong Lim; Michael A Kraus
Journal:  Clin Kidney J       Date:  2021-12-27

4.  Cardiac ischemia during hemolytic uremic syndrome.

Authors:  Meena Thayu; Wayne L Chandler; Srdjan Jelacic; Carrie A Gordon; Geoffrey L Rosenthal; Phillip I Tarr
Journal:  Pediatr Nephrol       Date:  2003-02-07       Impact factor: 3.714

5.  Impact of renal replacement therapy on the respiratory function of patients under mechanical ventilation.

Authors:  Fernanda Maia Lopes; José Roberval Ferreira; Dimitri Gusmao-Flores
Journal:  Rev Bras Ter Intensiva       Date:  2013 Jul-Sep

Review 6.  Intradialytic Hypoxemia in Chronic Hemodialysis Patients.

Authors:  Israel Campos; Lili Chan; Hanjie Zhang; Sheila Deziel; Cheryl Vaughn; Anna Meyring-Wösten; Peter Kotanko
Journal:  Blood Purif       Date:  2016-01-15       Impact factor: 2.614

7.  Sympathetic activation and baroreflex function during intradialytic hypertensive episodes.

Authors:  Dvora Rubinger; Rebecca Backenroth; Dan Sapoznikov
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

Review 8.  Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

Authors:  A M Macleod; M Campbell; J D Cody; C Daly; C Donaldson; A Grant; I Khan; K S Rabindranath; L Vale; S Wallace
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

9.  Prevalence and associated factors of undiagnosed atrial fibrillation among end-stage renal disease patients on maintenance haemodialysis: a cross-sectional study.

Authors:  Izzat AlAwwa; Reham Al-Hindi; Nadeen Alfraihat; Ahmad Obeid; Sarah Ibrahim; Shatha Jallad; Ahmad Al-Awwa; Akram Saleh
Journal:  BMC Cardiovasc Disord       Date:  2020-04-21       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.